Dr Turki Almugaiteeb, Chief Technical Officer, RPDC Innovations, Saudi Arabia

Annaliesa Anderson, Chief Scientific Officer, Bacterial Vaccines And The Hospital Business Unit, Pfizer, Pfizer, United States

Martin Bachmann, Professor of Immunology, University of Bern, Switzerland

Martin Bachmann | Professor of Immunology | University of Bern » speaking at Vaccine Europe

Pedro Ballester, Group Leader, INSERM, France

Andrew Bean, Chief Technology Officer, Commonwealth Scientific and Industrial Research Organisation, Australia

Andrew Bean | Chief Technology Officer | Commonwealth Scientific and Industrial Research Organisation » speaking at Vaccine Europe

Philip Beer, Physician Scientist And Precision Oncology Specialist, Sanger Institute, United Kingdom

Stephen Beers, Associate Professor, University Of Southampton, United Kingdom

Dr Dennis A Bente, Associate Professor, University of Texas Medical Branch, United States

Paolo Bonanni, Professor, Director, University of Florence, Italy

Dr Nicola Bonzanni, Chief Scientific Officer, ENPICOM, Netherlands

Dr Maria Elena Bottazzi, Co-Director, Texas Children’s Hospital Center for Vaccine Development, Baylor College of Medicine, United States

Amelie Boulais, Vaccine Platform Marketing Manager, Sartorius Stedim Biotech, France

Anissa Boumlic-Courtade, Associate Director Vaccine And Viral Therapies Emea, MERCK, France

Gabrielle Breugelmans, Director Of Research, Access to Medicine Foundation, Netherlands

Christopher Broder, Professor And Chair, Uniformed Services University, United States

Dr Kate Broderick, Vice President, Research And Development, Inovio Pharmaceuticals, United States

Adam Buckley, Vice President Business Development, VBI Vaccines, United States

Rosario Bullido, Head Of Vet Inmuno Medicines Assessment Unit, Aemps, Spain

Dr Benoit Callendret, Cdtl, Janssen Vaccines, Netherlands

Dr Benoit Callendret | Cdtl | Janssen Vaccines » speaking at Vaccine Europe

Andrea Carfi, Senior Director, Antigen Design And Selection, Infectious Diseases, Moderna Therapeutics, United States

Melisa Carpio, Global Technology Consultant, Sartorius Stedim Biotech, United States

Dr Miles Carroll, Deputy Director, Public Health England, United Kingdom

Jonathan Cartoux, Field Application Engineer Life Sciences Emea, ENTEGRIS, France

Dr Jean-Charles Cavitte, Research Policy Officer, European Commission, Belgium

Grace Chen, Deputy Chief Of The Clinical Trials Program In The Vrc, National Institutes of Health, United States

Richard Chin, Chief Executive Officer, Kindred Biosciences, Inc., United States

Magda Chlebus, Executive Director, Science Policy And Regulatory Affairs, EFPIA, Belgium

Magda Chlebus | Executive Director, Science Policy And Regulatory Affairs | EFPIA » speaking at Vaccine Europe

Dr Ralf Clemens, Senior Vice President, Grid Rio, Germany

Dr Ralf Clemens | Senior Vice President | Grid Rio » speaking at Vaccine Europe

Louise Cosby, Head Of Virology, Agri-Food and Biosciences Institute, United Kingdom

Dr Eric Cox, Director Of The Laboratory Of Immunology, University of Ghent, Belgium

Jakob Cramer, Head Of Clinical Development, CEPI

Jakob Cramer | Head Of Clinical Development | CEPI » speaking at Vaccine Europe

Thomas Cueni, Director General, International Federation of Pharmaceutical Manufacturers and Associations, Switzerland

Morena D'Alise, Lead Immunologist, Nouscom, Italy

Professor Jose De La Fuente, Head Of Genomics Group, Instituto De Investigacion En Recursos Cinegeticos Ronda De Toledo S/N, Spain

Professor Jose De La Fuente | Head Of Genomics Group | Instituto De Investigacion En Recursos Cinegeticos Ronda De Toledo S/N » speaking at Vaccine Europe

Isabel De La Mata, Principal Advisor For Health And Crisis Management, European Commission, Belgium

Noemi Garcia Del Blanco, Head of Veterinary Biologicals and Emerging therapies, European Medicines Agency, United Kingdom

Noemi Garcia Del Blanco | Head of Veterinary Biologicals and Emerging therapies | European Medicines Agency » speaking at Vaccine Europe

Don Diamond, Professor, Department Of Hematology And Hematopoietic Cell Transplantation, City Of Hope, United States

Carlota Dobano Lazaro, Associate Research Professor, Isglobal, Spain

Carel Du Marchie Sarvaas, Executive Director, HealthforAnimals, Belgium

Dr Baptiste Dungu, Chief Executive Officer, Onderstepoort Biological Products, Morocco

Marilyn Dysart, Clinical Affairs Manager, PharmaJet, United States

Victor Elinoff, President Medical Director, Regional Clinical Research, Inc., United States

Victor Elinoff | President Medical Director | Regional Clinical Research, Inc. » speaking at Vaccine Europe

Dr Brandon Essink, Medical Director, Meridian Clinical Research, United States

Thomas Evans, Vaccitech, United Kingdom

Roxane Feller, Secretary General, AnimalhealthEurope, Belgium

Dr Ivan Martinez Forero, Regional Clinical Director, MSD, Switzerland

Dr Ivan Martinez Forero | Regional Clinical Director | MSD » speaking at Vaccine Europe

Miguel Forte, Chief Executive Officer, Zelluna Immunotherapy, Norway

Agnete Fredriksen, President And Chief Scientific Officer, Vaccibody AS, Norway

Dr Martin Friede, Coordinator, Initiative For Vaccine Research Immunization, Vaccines And Biologicals Department, WHO, Switzerland

Leonard Friedland, Vice President, Scientific Affairs And Public Health Vaccines, North America, GSK, United States

Thomas Fuerst, Professor And Director, University of Maryland - Institute for Bioscience & Biotechnology Research, United States

Dr Dolores Gavier-Widén, Head Of Department, National Veterinary Institute SVA, Sweden

Dr Cyril Gay, Senior National Program Leader, A.R.S. National Programs, United States

Volker Gerdts, Director And Chief Executive Officer, VIDO-InterVac, Canada

Sarah Gilbert, Professor Of Vaccinology, University of Oxford, United Kingdom

William Gilbert, Lead Economic Analyst, H2020 SAPHIR Project, University of Liverpool, United Kingdom

William Gilbert | Lead Economic Analyst, H2020 SAPHIR Project | University of Liverpool » speaking at Vaccine Europe

Dr Gregory Glenn, President, Research And Development, Novavax, United States

Ulrike Gnad-Vogt, Chief Medical Officer, CureVac AG, Germany

Prof David Goldblatt, Professor Of Vaccinology And Immunology And Director Of Clinical Research And Development, UCL, United Kingdom

Dr Josie Golding, Lead, Wellcome Trust, United Kingdom

Oliver Gomez-Duran, Head Of Technical, Boehringer Ingelheim Animal Health, Germany

Oliver Gomez-Duran | Head Of Technical | Boehringer Ingelheim Animal Health » speaking at Vaccine Europe

Prof Herman Goossens, Professor, U.Z.A., Belgium

Prof Andrew Gorringe, Scientific Leader, P.H.E., United Kingdom

Tyre Grant, Senior Director, Elanco, United States

Tyre Grant | Senior Director | Elanco » speaking at Vaccine Europe

Dr Fumie Griego, Deputy Director General And Chief Operating Officer, International Federation of Pharmaceutical Manufacturers and Associations, Switzerland

Marion Gruber, Director Of Office For Vaccines, FDA, United States

Dr Bassam Hallis, Head Of Pre Clinical Development And General Project Manager, Public Health England, United Kingdom

Dr Bassam Hallis | Head Of Pre Clinical Development And General Project Manager | Public Health England » speaking at Vaccine Europe

Ahd Hamidi, Project Director, Batavia Biosciences, Netherlands

Dr Zdenko Herceg, Head, Section Of Mechanisms Of Carcinogenesis, International Agency for Research on Cancer (IARC/WHO), France

Dr Anders Høgset, Chief Scientific Officer, PCI Biotech, Norway

Barbara Holzer, Lead, Universal Flu Vaccine Studies, The Pirbright Institute, United Kingdom

Zahra Jawad, Group Leader Discovery Technology, Agenus, United Kingdom

Dr Robert Johnson, Director, Influenza And Emerging Infectious Diseases Division, HHS/BARDA, United States

Sune Justesen, Chief Scientific Officer, Immunitrack ApS, Denmark

Sune Justesen | Chief Scientific Officer | Immunitrack ApS » speaking at Vaccine Europe

Dr Tobias Kamphuis, Project Leader Viral Vaccines, Janssen, Netherlands

Professor Lana Kandalaft, Director, Center Of Experimental Therapeutics, University of Lausanne, Switzerland

Theo Kanellos, Director of Business Development & Alliances, Zoetis, France

Dr Elzo Kannekens, Director, MSD Animal Health, Belgium

Andreas Katopodis, Chief Executive Officer, Anaveon, Switzerland

Hans Keirstead, Chief Executive Officer, AiVita Biomedical, United States

Barbara Kerstiens, Deputy Head Of Unit, Fighting Infectious Diseases And Advancing Public Health Research And Innovatio, European Commission, Belgium

Jeremy Knox, Jeremy Knox, Director Of Policy, Drug Resistant Infections,, Wellcome Trust, United Kingdom

Wayne Koff, President And Chief Executive Officer, The Human Vaccines Project, United States

Alexander Koglin, Founder, NTxBio, United States

Dr Alexander Kort, Senior Vice President Corporate Development, Themis Bioscience, Austria

Gergely Krajcsi, Investment Officer, European Investment Bank, Luxembourg

David Krige, Head Of Biomarkers, Psioxus Therapeutics Ltd, United Kingdom

Teresa Lambe, Associate Professor, University of Oxford, United Kingdom

Renate Lamprecht, Portfolio Manager, Afrigen Biologics (Pty) Ltd, South Africa

Nathalie Landry, Executive Vice President, Medicago, Canada

Alexandre Le Vert, Chief Executive Officer And Co-Founder, Osivax, France

Valérie Lecouturier, Head of Research Unit, Sanofi Pasteur, France

Anders Lilja, Senior Vice President Of Technical Development, Hookipa Biotech, Austria

Dr Yong-Jie Lu, Professor In Molecular Oncology, Queen Mary University of London, United Kingdom

Dr Yong-Jie Lu | Professor In Molecular Oncology | Queen Mary University of London » speaking at Vaccine Europe

Martin Ludlow, Group Leader, Research Center for Emerging Infections and Zoonoses (RIZ), Germany

Martin Ludlow | Group Leader | Research Center for Emerging Infections and Zoonoses (RIZ) » speaking at Vaccine Europe

Charles Lutsch, Avp R, Sanofi Pasteur, United States

Dr Anthony Simon Lynch, Senior Scientific Director, Janssen R&D, Netherlands

Cristina Muñoz Madero, Senior Assessor, Agencia Española de Medicamentos y Productos Sanitarios, Spain

Dr Kutub Mahmood, Scientific Director, Path, United States

Dr Michael Makanga, Executive Director, E.D.C.T.P., Netherlands

Prof Harris Makatsoris, Professor, Cranfield University, United Kingdom

Mary Marovich, Director Of Vaccine Research Program, NIAID, NIH, United States

Ariane Mccabe, Director, Global Health And Public Affairs, Glaxosmithkline, Switzerland

Ariane Mccabe | Director, Global Health And Public Affairs | Glaxosmithkline » speaking at Vaccine Europe

Dr Kees Melief, Chief Scientific Officer, I.S.A. Pharmaceuticals Bv, Netherlands

Dr Martin Mengel, Global-Health Consulting, Spain

Jacqueline Miller, Vice President And Head, Clinical Randd, GSK Biologicals, United States

Joanna Miller, Chief Scientific Officer, Cell Therapy Sciences, United Kingdom

Ann Moen, Chief, World Health Organisation, Switzerland

Ann Moen | Chief | World Health Organisation » speaking at Vaccine Europe

Yalda Momeni, Contracts Manager - Epi Routine Vaccines, UNICEF, Denmark

Yalda Momeni | Contracts Manager - Epi Routine Vaccines | UNICEF » speaking at Vaccine Europe

Marjorie Monnet, Fermentation Unit Head, Sanofi Pasteur, United States

Marjorie Monnet | Fermentation Unit Head | Sanofi Pasteur » speaking at Vaccine Europe

Emanuele Montomoli, Professor In Public Health University Of Siena And Chief Scientific Officer, VisMederi, Italy

Melinda Moree, Senior Business Development Consultant, CEPI, United States

Melinda Moree | Senior Business Development Consultant | CEPI » speaking at Vaccine Europe

Merribeth Morin, Carb-X Lead, Boston University, United States

Merribeth Morin | Carb-X Lead | Boston University » speaking at Vaccine Europe

Dr Alex Morrow, Chair Of The International Research Consortium, STAR-IDAZ, United Kingdom

Rasmus Mortensen, Head Of Section, Tb Vaccine Development, Statens Serum Institut, Denmark

Musa Mulongo, Senior Program Specialist, IDRC, Kenya

Dr Mel Munro, Project Manager, Biologicals Regulatory Affairs, Triveritas Limited, United Kingdom

Dr Mel Munro | Project Manager, Biologicals Regulatory Affairs | Triveritas Limited » speaking at Vaccine Europe

Imraan Munshi, Executive Director And Global Communications Lead For Vaccines, Merck & Co Inc, United States

Dr Hans Nauwynck, Professor, Gent University, Belgium

Emma Navarro, Vice President, European Investment Bank, Luxembourg

Dr Christopher Netherton, Principal Investigator, The Pirbright Institute, United Kingdom

Dr Andreas Neubert, Vice President Vaccines, IDT Biologika, Germany

Dr Alasdair Nisbet, Head Of Vaccine Research, Moredun Research Institute, Moredun Research Institute, United Kingdom

Mikkel Nissum, Technical Development Leader, GSK Vaccine, Italy

Dr Paolo Nuciforo, Head Molecular Oncology Group, Vall d’Hebron Institute of Oncology (VHIO), Spain

Gráinne O'Rourke, Former Head Of Communications, Irish Cancer Society, Ireland

Ab Osterhaus, Director, Research Center For Emerging Infections And Zoonoses (Riz), University of Veterinary Medicine Hannover, Netherlands

Dr Niels Pallisgaard, Molecular Biologist, Zealand University Hospital, Denmark

Serafino Pantano, Director, Biomarker And Diagnostics Leader, Merck Sharp & Dohme, Switzerland

Christopher Parks, Executive Director, International Aids Vaccine Initiative, United States

Mark Pearson, Deputy Director, Employment, Labour And Social Affairs, O.E.C.D., France

Dr Wolfgang Philipp, Head Of Unit, The European Comission, Belgium

Mariagrazia Pizza, Senior Scientific Director,, Glaxosmithkline, Italy

Gregory Poland, Director Of Mayo Vaccine Research Group, Mayo Clinic, United States

Dr Jan Poolman, Head Bacterial Vaccine Discovery And Early Development, Janssen, Netherlands

Dr Sheuli Porkess, Executive Director, Association of the British Pharmaceutical Industry-ABPI, United Kingdom

Dr Alexander Precioso, Director, Instituto Butantan, Brazil

Lois Privor-Dumm, Director, Policy, Advocacy And Communications, IVAC, Johns Hopkins Bloomberg School of Public Health, United States

Laszlo Radvanyi, President And Scientific Director, Ontario Institute for Cancer Research, Canada

Saeed Rafii, Medical Director, Roche, United Kingdom

Saeed Rafii | Medical Director | Roche » speaking at Vaccine Europe

Dr S Ravetkar, Executive Director, Serum Institute of India Ltd, India

Dr Steven Reed, Founder, Distinguished Scientist, Infectious Disease Research Institute, United States

Guus Rimmelzwann, Alexader Von Humboldt Professor, University of Veterinary Medicine Hannover, Germany

Dr Fernando Rodriguez, Head Of The Animal Health Program, IRTA-CReSA, Spain

Simona Rondini, Vaccine Development Lead, Copd Vaccine, GSK Vaccines, Italy

Stephen J Russell, Director, Chief Executive Officer And President, Vyriad, United States

Dr Arturo Reyes Sandoval, Associate Professor, University of Oxford, United Kingdom

Dr Melanie Saville, Director Of Vaccine Development- Uk, CEPI, France

Aaron Schacht, Executive Vice President - Innovation, Regulatory And Business Development, Elanco Animal Health, United States

Silke Schepelmann, Principal Scientist, National Institute for Biological Standards and Control, United Kingdom

Dr Hanneke Schuitemaker, Vice President And Head Of Viral Vaccine Discovery And Translational Medicine, Janssen, Netherlands

Dr Will Singleterry, Director Of Business Development, IsoPlexis, United States

William Smith, Chief Executive Officer, Alliance for Multispecialty Research LLC, United States

Dr Jan Spaas, Chief Executive Officer, Global Stem Cell Technology, Belgium

Bruno Speder, Head Of Clinical Regulatory Affairs, SGS Life Sciences, Belgium

Dr Julia Spencer, Associate Vice President, Global Vaccine Public Policy, Partnerships, Merck, United States

Dr Julia Spencer | Associate Vice President, Global Vaccine Public Policy, Partnerships | Merck » speaking at Vaccine Europe

Dr Erin Spiegel, Director Of Scientific Affairs, PharmaJet, United States

Prof Karen-Lise Spindle, Aarhus University, Denmark

Prof Karen-Lise Spindle |  | Aarhus University » speaking at Vaccine Europe

Lucilla Steinaa, Principle Scientist, International Livestock Research Institute, Kenya

Dr Gerd Sutter, Full Professor And Chair For Virology, Director, Department Of Veterinary Sciences, Lmu Munich, Germany

Dr Nigel Swift, Global Head Of Vaccine Research And Development, Boehringer Ingelheim, United Kingdom

Dr Nigel Swift | Global Head Of Vaccine Research And Development | Boehringer Ingelheim » speaking at Vaccine Europe

Dr Raymond Tesi, Chief Executive Officer, INmune Bio, United States

Samuel Thevasagayam, Deputy Director, Global Development, The Bill & Melinda Gates Foundation, United States

Dr Joris Vandeputte, President, IABS, Belgium

Dr Jonathan Van-Tam, Deputy Chief Medical Officer, UK Department of Health, United Kingdom

Sanjay Vashee, Associate Professor, J. Craig Venter Institute, United Kingdom

Thomas Verstraeten, Managing Director P95, P95, Belgium

Gerald Voss, Scientific Director, TuBerculosis Vaccine Initiative, Netherlands

Prof Jaap Wagenaar, Professor Veterinary Medicine, University of Utrecht, Netherlands

Markus Waldhuber, Co-Founder And Scientific Leader, Adivo GmbH, Germany

Kelly Lyn Warfield, Vice President Of Vaccines, Anti-Infectives, Research And Development, Emergent Biosolutions, United States

Emma Wheatley, Head Of Collaborations And Deputy General Counsel, CEPI, United Kingdom

Emma Wheatley | Head Of Collaborations And Deputy General Counsel | CEPI » speaking at Vaccine Europe

Tony Whetton, Director, Stoller Biomarker Discovery Centre, United Kingdom

Tony Whetton | Director | Stoller Biomarker Discovery Centre » speaking at Vaccine Europe

Annelies Wilder-Smith, Professor Of Infectious Disease, Principal Investigator For Vaccine Preventable Diseases & Emerging, Nanyang Technological University, Singapore

Adrian Wildfire, Scientific Director - Infectious Diseases And Viral Infection Unit, SGS Life Science Services, United Kingdom

Sign Up for Event Updates